Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares are currently rising almost 8% after the biotech firm released the rare, good news that its drug in …
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) revealed yesterday evening that its Board of Directors has chosen Dr. Richard Glickman, the biotech firm’s founder and Chairman, …
As REDUCE-IT continues to track to expected read-outs in early 2018, H.C.
OHR Pharmaceutical Inc (NASDAQ:OHRP) is confronting the aftermath of Fovista’s pivotal two Phase 3 failures that both missed the primary endpoint in neovascular …
In a research report published Monday, H.C.
Nivalis Therapeutics Inc (NASDAQ:NVLS) investors are heading for the hills after the drug maker reported that the Phase 2 study of cavosonstat as an …
On November 9th, AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) posted third-quarter financial earnings and held a conference call.
Inovio Pharmaceuticals Inc (NASDAQ:INO) released third-quarter financial earnings and a clinical progress update on the firm’s pipeline on Wednesday, November 9th. H.
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) just scored what H.C.
In a research report published Wednesday, H.C.